Cytochrome P450 Activity in Ex Vivo Cornea Models and a Human Cornea Construct.

The pharmacokinetic behaviors of novel ophthalmic drugs are often preliminarily investigated in preclinical studies using ex vivo animal cornea or corneal cell culture models. During transcorneal passage, topically applied drugs may be affected by drug metabolizing enzymes. The knowledge regarding the functional expression of metabolic enzymes in corneal tissue is marginal; thus, the aim of this study was to investigate cytochrome P450 activity in an organotypic three-dimensional human cornea construct and to compare it with porcine and rabbit corneas, which are commonly used ex vivo cornea models. The total cytochrome P450 activity was determined by measuring the transformation of 7-ethoxycoumarin. Furthermore, the expression of the cytochrome P450 enzyme 2D6 (CYP2D6) was investigated at the protein level using immunohistochemistry and western blotting. CYP2D6 activity measurements were performed using a d-luciferin-based assay. In summary, similar levels of the total cytochrome P450 activity were identified in all 3 cornea models. The protein expression of CYP2D6 was confirmed in the human cornea construct and porcine cornea, whereas the signals in the rabbit cornea were weak. The analysis of the CYP2D6 activity indicated similar values for the human cornea construct and porcine cornea; however, a distinctly lower activity was observed in the rabbit cornea.

[1]  F. Guengerich,et al.  Contributions of human enzymes in carcinogen metabolism. , 2012, Chemical research in toxicology.

[2]  A. Mitra,et al.  Drug Delivery to the Eye , 2005 .

[3]  N. V. van Haeringen,et al.  Corneal Aldehyde Dehydrogenase, Glutathione Reductase, and Glutathione S-Transferase in Pathologic Corneas , 1993, Cornea.

[4]  G. Putterman,et al.  Lack of metabolism of timolol by ocular tissues. , 1985, Journal of ocular pharmacology.

[5]  S. Reich,et al.  Entwicklung eines organotypischen Korneakonstruktes als ein In-vitro-Modell für Permeationsstudien , 2001, Der Ophthalmologe.

[6]  J. Masferrer,et al.  Cytochrome P450 dependent metabolism of arachidonic acid in bovine corneal epithelium. , 1985, Biochemical and biophysical research communications.

[7]  T. Leff,et al.  Regulation of cytochrome P450 in cultured human colonic cells. , 1993, Archives of biochemistry and biophysics.

[8]  H. Kautiainen,et al.  Ophthalmic timolol in a hydrogel vehicle leads to minor inter-individual variation in timolol concentration in aqueous humor. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  M. Prausnitz,et al.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. , 1998, Journal of pharmaceutical sciences.

[10]  Stephan Reichl,et al.  Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics. , 2010, International journal of pharmaceutics.

[11]  S Reichl,et al.  Cultivation and characterization of a bovine in vitro model of the cornea. , 2004, Die Pharmazie.

[12]  L. Meyer,et al.  Esteraseaktivität eines organotypischen humanen Kornea-Konstrukts (HCC) als In-vitro-Modell für Permeationsuntersuchungen , 2005, Der Ophthalmologe.

[13]  S. Yamamoto,et al.  Purification and cDNA cloning of human liver CYP4A fatty acid omega-hydroxylase. , 1994, Journal of biochemistry.

[14]  D. Nebert,et al.  Genetic differences in drug metabolism associated with ocular toxicity. , 1982, Environmental health perspectives.

[15]  S. Coupland,et al.  Hydrolases of anterior segment tissues in the normal human, pig and rat eye: a comparative study , 1994, Graefe's Archive for Clinical and Experimental Ophthalmology.

[16]  Stephan Reichl,et al.  Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  J. Falck,et al.  Hypoxia stimulates the synthesis of cytochrome P450-derived inflammatory eicosanoids in rabbit corneal epithelium. , 1998, The Journal of pharmacology and experimental therapeutics.

[18]  Stephan Reichl,et al.  In vitro cell culture models to study the corneal drug absorption , 2011, Expert opinion on drug metabolism & toxicology.

[19]  Stephan Reichl,et al.  Cell culture models of the human cornea — a comparative evaluation of their usefulness to determine ocular drug absorption in‐vitro , 2008, The Journal of pharmacy and pharmacology.

[20]  A. Urtti,et al.  Culture model of human corneal epithelium for prediction of ocular drug absorption. , 2001, Investigative ophthalmology & visual science.

[21]  J. Hochman,et al.  Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[22]  David J. Liu,et al.  Luminogenic cytochrome P450 assays , 2006, Expert opinion on drug metabolism & toxicology.

[23]  Stephan Reichl,et al.  Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies. , 2012, Journal of pharmaceutical sciences.

[24]  Stephan Reichl,et al.  Toward the practical implementation of eye-related bioavailability prediction models. , 2014, Drug discovery today.

[25]  M. Engelke,et al.  A Human Corneal Equivalent Constructed from SV40-immortalised Corneal Cell Lines , 2005, Alternatives to laboratory animals : ATLA.

[26]  H. Handa,et al.  An SV40-immortalized human corneal epithelial cell line and its characterization. , 1995, Investigative ophthalmology & visual science.

[27]  V. Rogiers,et al.  Effect of epidermal growth factor in collagen gel cultures of rat hepatocytes. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[28]  H. Shichi,et al.  Enzymes of mercapturate synthesis and other drug-metabolizing reactions-specific localization in the eye. , 1981, Experimental eye research.

[29]  W M Petroll,et al.  Epithelial and corneal thickness measurements by in vivo confocal microscopy through focusing (CMTF). , 1997, Current eye research.

[30]  F. Guengerich,et al.  Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. , 2001, Chemical research in toxicology.

[31]  Tao Zhang,et al.  Drug Transporter and Cytochrome P450 mRNA Expression in Human Ocular Barriers: Implications for Ocular Drug Disposition , 2008, Drug Metabolism and Disposition.

[32]  V. Vasiliou,et al.  Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea. , 2003, The Biochemical journal.

[33]  J. Masferrer,et al.  Cytochrome P450, drug metabolizing enzymes and arachidonic acid metabolism in bovine ocular tissues. , 1987, Current eye research.

[34]  C. Ehrhardt,et al.  A Comparative Evaluation of Corneal Epithelial Cell Cultures for Assessing Ocular Permeability , 2008, Alternatives to laboratory animals : ATLA.

[35]  O. Pelkonen,et al.  Timolol Metabolism in Human Liver Microsomes Is Mediated Principally by CYP2D6 , 2007, Drug Metabolism and Disposition.

[36]  Barry C. Jones,et al.  DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS , 2004, Drug Metabolism and Disposition.

[37]  A. Parkinson,et al.  Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. , 1996, Archives of biochemistry and biophysics.

[38]  H. Shichi,et al.  Cytochrome P450-mediated prostaglandin ωω-1 hydroxylase activities in porcine ciliary body epithelial cells , 1992 .

[39]  Stephan Reichl,et al.  Multidrug resistance-associated protein (MRP1, 2, 4 and 5) expression in human corneal cell culture models and animal corneal tissue. , 2014, Molecular pharmaceutics.

[40]  Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. , 1998 .

[41]  J. Fogh,et al.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors. , 1977, Journal of the National Cancer Institute.

[42]  R. Ebel,et al.  Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction. , 1976, The Journal of biological chemistry.

[43]  Stephan Reichl,et al.  Expression analysis of MDR1, BCRP and MRP3 transporter proteins in different in vitro and ex vivo cornea models for drug absorption studies. , 2013, International journal of pharmaceutics.

[44]  T. Aoyama,et al.  Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. , 1991, Archives of biochemistry and biophysics.

[45]  M. Schwartzman,et al.  Hypoxia-induced production of 12-hydroxyeicosanoids in the corneal epithelium: involvement of a cytochrome P-4504B1 isoform. , 1999, The Journal of pharmacology and experimental therapeutics.

[46]  A. Mitra,et al.  Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line. , 2001, Journal of pharmaceutical sciences.

[47]  D. Waxman,et al.  Use of 7-ethoxycoumarin to monitor multiple enzymes in the human CYP1, CYP2, and CYP3 families. , 1998, Methods in molecular biology.

[48]  M. Schwartzman,et al.  Effect of metabolic inhibitors on arachidonic acid metabolism in the corneal epithelium: evidence for cytochrome P450-mediated reactions. , 1994, Journal of ocular pharmacology.

[49]  M. Jurima‐Romet,et al.  Evidence for the catalysis of dextromethorphan O-demethylation by a CYP2D6-like enzyme in pig liver. , 2000, Toxicology in vitro : an international journal published in association with BIBRA.

[50]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[51]  J. Prause,et al.  Corneal Thickness in Pigs Measured by Ultrasound Pachymetry In Vivo , 2008 .

[52]  S. Reichl,et al.  mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[53]  P. Friedl,et al.  Immortalization of human corneal endothelial cells using electroporation protocol optimized for human corneal endothelial and human retinal pigment epithelial cells. , 2000, Acta ophthalmologica Scandinavica.

[54]  K. Tsubota,et al.  Corneal damage and lacrimal gland dysfunction in a smoking rat model. , 2011, Free radical biology & medicine.

[55]  B. Sjöquist,et al.  Ocular and systemic pharmacokinetics of latanoprost in humans. , 2002, Survey of ophthalmology.

[56]  D. Greco,et al.  Gene expression analysis in SV-40 immortalized human corneal epithelial cells cultured with an air-liquid interface , 2010, Molecular vision.

[57]  S Reichl,et al.  Human corneal equivalent as cell culture model for in vitro drug permeation studies , 2004, British Journal of Ophthalmology.

[58]  N. Burstein,et al.  Corneal penetration and ocular bioavailability of drugs. , 1985, Journal of ocular pharmacology.